Fluid and diuretic therapy in heart failure

Fluid, Electrolyte and Acid-Base Disorders in Small Animal Practice

Volumn , Issue , 2006, Pages 490-518

  Bonagura, John D ^a,b   Lehmkuhl, Linda B ^c   de Morais, Helio Autran ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MedVet Medical Center for Pets   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880676778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-163949-6/50024-2     Document Type: Chapter

References (176)

1. Abbott JA Beta-blockade in the management of systolic dysfunction. Vet Clin North Am Small Anim Pract 2004, 34:1157-1170.
2. Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med 2003, 17:632-636.
3. Amberger CN, Glardon O, Glaus T, et al. Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy: results of a prospective, open-label, multicenter clinical trial. J Vet Cardiol 1999, 1:19-26.
4. Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999, 61:523-529.
5. Atkins CE, Brown WA, Coats JR, et al. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. J Am Vet Med Assoc 2003, 221:654-658. (Erratum in J Am Vet Med Assoc 15:221:1149, 2002).
6. Auld RB, Alexander EA, Levinsky NG Proximal tubular function in dogs with thoracic caval constriction. J Clin Invest 1971, 50:2150-2158.
7. Barger AC, Yates FE, Rudolph AM Renal hemodynamics and sodium excretion in dogs with graded valvular damage, and in congestive failure. Am J Physiol 1961, 200:601-608.
8. Bonagura JD, Lehmkuhl LB Fluid therapy in heart failure. Fluid therapy in small animal practice 1992, 529-553. WB Saunders, Philadelphia. ed 1. S.J. DiBartola (Ed.).
9. Bonagura JD, Rush J Heart failure. Saunders manual of small animal practice 2000, WB Saunders, Philadelphia. ed 2. S.J. Birchard, R.G. Sherding (Eds.).
10. Bonagura JD, Ware WA Atrial fibrillation in the dog: clinical findings in 81 cases. J Am Anim Hosp Assoc 1986, 22:111-120.
11. Bourland WA, Day DK, Williams HE The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther 1977, 202:221-229.
12. Bristow MR Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997, 80:26L-40L.
13. Calvert CA, Rawlings CA Canine heartworm disease. Canine and feline cardiology 1988, 519-549. Churchill Livingstone, New York. P.R. Fox (Ed.).
14. Cannon PJ The kidney in heart failure. N Engl J Med 1977, 296:26-32.
15. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation 2004, 109:1680-1685.
16. Chen HH, Grantham JA, Schirger JA, et al. Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol 2000, 36:1706-1712.
17. Clark AL, Poole-Wilson PA, Coats AJ Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996, 28:1092-1102.
18. Cobb M, Michell AR Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J Small Anim Pract 1992, 33:526-529.
19. Cogan MG Atrial natriuretic peptide. Kidney Int 1990, 37:1148. 1160.
20. Cohn JN, Levine TB Angiotensin-converting enzyme inhibition in congestive heart failure: the concept. Am J Cardiol 1982, 49:1480-1483.
21. Cohn JN, Levine TB, Olivar MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819-823.
22. Co-operative Veterinary Enalapril (COVE) Study Group: Controlled clinical evaluation of enalapril in dogs with heart failure-results of the Cooperative Veterinary Enalapril Study Group. J Vet Intern Med 1995, 9:243-252.
23. Creager MA, Cusco JA Treatment of congestive heart failure with angiotensin-converting enzyme inhibitors. Heart failure 1995, 316-344. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
24. Creager MA, Halperin JL, Bernard DB, et al. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation 1981, 64:483-489.
25. Decarli C, Spouse G, Larosa JL Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 1986, 57:956-959.
26. Dirks JH, Cirksena WJ, Berliner RW Micropuncture study of the effect of various diuretics on sodium reabsorption by the proximal tubules of the dog. J Clin Invest 1966, 45:1875-1885.
27. Dormans TP, Pickkers P, Russel FG, et al. Vascular effects of loop diuretics. Cardiovasc Res 1996, 32:988-997.
28. Dormans TP, van Meyel JJ, Gerlag PG, et al. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996, 28:376-382.
29. Dow SJ, Fettman MJ, Smith KR, et al. Taurine depletion and cardiovascular disease in adult cats fed a potassium-depleted acidified diet. Am J Vet Res 1992, 53:402-405.
30. Dumont AE, Clauss RH, Reed GE, et al. Lymph drainage in patients with congestive heart failure: comparison with findings in hepatic cirrhosis. N Engl J Med 1963, 269:949-952.
31. Dzau VJ, Hollenberg NK Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 1984, 100:777-781.
32. Dzau VJ, Swartz SL Dissociation of the prostaglandin and renin-angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1987, 60:1101-1105.
33. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981, 63:645-651.
34. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984, 310:347-352.
35. Eaton GE, Cody RJ, Brinkley PF Increase in aortic impedance precedes peripheral vasoconstriction at the early stage of ventricular failure in the paced canine model. Circulation 1993, 88:2714-2721.
36. Edwards JN: Magnesium and congestive heart failure. Proceedings of the American College of Veterinary Internal Medicine, New Orleans, 1991, pp. 679-680.
37. Fenelon G, Protter AA, Stambler BS Examination of the in vivo cardiac electrophysiological effects of nesiritide (human brain natriuretic peptide) in conscious dogs. J Card Fail 2002, 8:320-325.
38. Feuerstein GZ, Yue TL, Cheng HY, et al. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens Suppl 1993, 11:S41-S48.
39. Fichman MP, Vorherr H, Kleeman CR, et al. Diuretic-induced hyponatremia. Ann Intern Med 1971, 75:853-863.
40. Forrester JS, Diamond G, Chatterjee K, et al. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976, 295:1404-1413.
41. Franciosa JA, Dunkman WB, Wilen M, et al. "Optimal" left ventricular filling pressure during nitroprusside infusion for congestive heart failure. Am J Med 1983, 74:457-464.
42. Francis GS, McDonald KM Neurohumoral mechanisms in heart failure. Heart failure 1995, 90-116. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
43. Francis GS, Goldsmith SR, Levine TB, et al. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984, 101:370-377.
44. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985, 103:1-6.
45. Francis GS Neurohumoral mechanisms involved in congestive heart failure. Am J Cardiol 1985, 55:15A-21A.
46. Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998, 12:440-448.
47. Freeman RH, Davis JD, Williams GM, et al. Effects of the oral angiotensin converting enzyme inhibitor, SQ 14225 in a model of low cardiac output in dogs. Circ Res 1979, 45:540-545.
48. Friedman E, Shadel M, Halkin H, et al. Thiazide-induced hyponatremia. Ann Intern Med 1989, 110:24-30.
49. Fulop M, Horowitz M, Aberman A, et al. Lactic acidosis in pulmonary edema due to left ventricular failure. Ann Intern Med 1973, 79:180-186.
50. Gaasch WH, Freeman GL Functional properties of normal and failing hearts. Heart failure 1995, 14-29. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
51. Gerlag PGG, van Meijel JJM High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med 1988, 148:286-291.
52. Gottlieb SS, Weir MR Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure. Am J Cardiol 1990, 66:14D-21D.
53. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002, 8:136-141.
54. Granger JP Regulation of sodium excretion by renal interstitial hydrostatic pressure. Fed Proc 1986, 45:2892-2896.
55. Greco DS, Biller B, Van Liew CH Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 2003, 44:293-297.
56. Guyton AC, Lindsey AW Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959, 7:649-657.
57. Haggstrom J, Hansson K, Karlberg BE, et al. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am J Vet Res 1996, 57:1645-1652.
58. Hall JE, Guyton AC, Jackson TE, et al. Control of glomerular filtration rate by the renin-angiotensin system. Am J Physiol 1977, 233:F366-F372.
59. Hamlin RL, Smith RC, Powere TE, et al. Efficacy of various diuretics in normal dogs. J Am Vet Med Assoc 1965, 146:1417-1420.
60. Heinemann HO Right-sided heart failure and the use of diuretics. Am J Med 1978, 64:367-369.
61. Higgins CB, Vatner SF, Eckberg DL, et al. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 1972, 51715-51724.
62. Hirsch AT, Muellerleile M, Dzau VJ Cardiovascular tissue angiotensin systems: activation and actions in heart failure. Heart failure 1995, 117-134. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
63. Hirsch AT, Pinto YM, Schunkert H, et al. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 1990, 66:22D-32D.
64. Hollander W, Judson WE The relationship of cardiovascular and renal hemodynamic function to sodium excretion in patients with severe heart disease but without edema. J Clin Invest 1956, 35:970-979.
65. Ichikawa I, Pfeffer JM, Pfeffer MA, et al. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 1984, 55:669-675.
66. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter Prospective Veterinary Evaluation of Enalapril study. J Vet Intern Med 1995, 9:234-242. IMPROVE Study Group.
67. Jackson EK Diuretics. Goodman & Gilman's the pharmacological basis of therapeutics 1996, 685-714. McGraw-Hill, New York. ed 9. J.G. Hardman, L.E. Limbird, P.B. Molinoff (Eds.).
68. Jensen KT, Carstens J, Pedersen EB Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 1998, 274:F63-F72.
69. Kaloyanides GJ Pathogenesis and treatment of edema with special reference to the use of diuretics. Clinical disorders of fluid and electrolyte metabolism 1980, 647-701. McGraw-Hill, New York. M.H. Maxwell, C.R. Kleeman (Eds.).
70. Katz AM Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med 1990, 322:100-110.
71. Keane WR, Shapiro BE Renal protective effects of angiotensin-converting enzyme inhibition. Am J Cardiol 1990, 65:491-531.
72. Keene BW, Rush JE Therapy of heart failure. Textbook of veterinary internal medicine 1989, 939-975. WB Saunders, Philadelphia. ed 3. S.J. Ettinger (Ed.).
73. Khanna C, Lund EM, Raffe M, et al. Hypomagnesemia in 188 dogs: a hospital population-based prevalence study. J Vet Intern Med 1998, 12:304-309.
74. Kim S, Iwao H Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2001, 52:11-34.
75. Kinugawa T, Thames MC Baroreflexes in heart failure. Heart failure 1995, 30-45. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
76. Kitagawa H, Wakamiya H, Kitoh K, et al. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. J Vet Med Sci 1997, 59:513-520.
77. Kittleson M, Keene B, Pion PD, et al. Results of the Multicenter Spaniel Trial (MUST): taurine and carnitine responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. J Vet Intern Med 1997, 11:204-211.
78. Knowlen GG, Kittleson MD, Nachreiner RF, et al. Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure. J Am Vet Med Assoc 1983, 183:991-996.
79. Koch J, Pedersen HD, Jensen AL, et al. Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci 1995, 59:172-175.
80. Kubo SH Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure. Circulation 1990, 81(suppl III):107-114.
81. Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002, 16:80-88.
82. Levens NR Control of renal function by intrarenal angiotensin II in the dog. J Cardiovasc Pharmacol 1990, 16(suppl 4):565-569.
83. Levin A, Djurdjev O, Barret B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis 2001, 38:1398-1407.
84. Levine TB, Francis GS, Goldsmith SR, et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982, 49:1659-1666.
85. Levy M Effects of acute volume expansion and altered hemodynamics on renal tubular function in chronic caval dogs. J Clin Invest 1972, 51:922-938.
86. Licata G, Di Pasquale P, Parrinello G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459-466.
87. Lifschitz MD, Schrier RW Alterations in cardiac output with chronic constriction of thoracic inferior vena cava. Am J Physiol 1973, 225:1364-1370.
88. Little CJ, Julu PO, Hansen S, et al. Non-invasive real-time measurements of cardiac vagal tone in dogs with cardiac disease. Vet Rec 2005, 156:101-105.
89. Luis Fuentes V Use of pimobendan in the management of heart failure. Vet Clin North Am Small Anim Pract 2004, 34:1145-1155.
90. MacDonald KA, Kittleson MD, Munro C, et al. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 2003, 17:172-177.
91. Margulies KG, Hilderbrand FL, Lerman A, et al. Increased endothelin in experimental heart failure. Circulation 1990, 82:2226-2232.
92. Mettauer B, Roulearu J-L, Bichet D, et al. Sodium and water excretion abnormalities in congestive heart failure. Ann Intern Med 1986, 105:161-167.
93. Michell AR Physiological aspects of the requirement for sodium in mammals. Nutr Res Rev 1989, 2:149-160.
94. Migdal S, Alexander EA, Levinsky NG Evidence that decreased cardiac output is not the stimulus to sodium retention during acute constriction of the vena cava. J Lab Clin Med 1977, 89:809-816.
95. Millard RW, Higgins CB, Franklin D, et al. Regulation of the renal circulation during severe exercise in normal dogs and dogs with experimental heart failure. Circ Res 1972, 31:881-888.
96. Miller WC, Simi WW, Rice DL Contribution of systemic venous hypertension to the development of pulmonary edema in dogs. Circ Res 1978, 43:598-600.
97. Molina CR, Fowler MB, McCrory S, et al. Hemodynamic, renal, and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol 1988, 12:175-186.
98. Morita H, Suzuki G, Mishima T, et al. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Cardiovasc Drugs Ther 2002, 16:443-449.
99. Morris ML, Patton RL, Teeter SM Low sodium diet in heart disease: how low is low?. Vet Med Small Anim Clin 1976, 9:1225-1227.
100. Munagala VK, Burnett JC, Redfield MM The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol 2004, 29:707-769.
101. Naitoh M, Suzuki H, Murakami M, et al. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 1994, 267:H2245-H2254.
102. Nomura A, Yasuda H, Minami M, et al. Effect of furosemide in congestive heart failure. Clin Pharmacol Ther 1981, 30:177-182.
103. O'Connor CM, Gattis WA, Swedberg K Current and novel pharmacologic approaches in advanced heart failure. Am Heart J 1998, 135:S249-S263.
104. Oliver JA, Sciacca RR, Pinto J, et al. Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest 1981, 67:229-237.
105. Opie LH, Kaplan NM Diuretics. Drugs for the Heart 2005, 80-103. Elsevier/WB Saunders, Philadelphia. ed 6. L.H. Opie, B.J. Gersh (Eds.).
106. Opie LH Heart physiology: from cell to circulation 2003, Lippincott Williams & Wilkins, Baltimore. ed 4.
107. Osborn JL, Holdaas H, Thames MD, et al. Renal adrenoreceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog. Circ Res 1983, 53:298-305.
108. Oster JR, Epstein M, Smoller S Combination therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med 1983, 99:405-406.
109. Packer M, Lee WH, Kessler PD Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation 1986, 74:766-774.
110. Packer M, Lee WH, Medina N, et al. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987, 106:346-354.
111. Packer M, Lee WH, Medina N, et al. Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. Ann Intern Med 1986, 104:147-154.
112. Packer M, McMurray J, Massie BM, et al. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail 2005, 11:12-20.
113. Packer M, Medina N, Yshak M Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann Intern Med 1984, 100:782-789.
114. Packer M Neurohumoral interactions and adaptations in congestive heart failure. Am J Cardiol 1985, 55:1A-10A.
115. Paradiso G, Bakris GL, Stein JH The kidney and heart failure. Heart failure 1995, 135-158. Chapman & Hall, New York. D. McCall, S.H. Rahimtoola (Eds.).
116. Parmley WW Pathophysiology of congestive heart failure. Am J Cardiol 1985, 55:9A-14A.
117. Patak RV, Fadem SZ, Rosenblatt SG, et al. Diuretic-induced changes in renal blood flow and prostaglandin E excretion in the dog. Am J Physiol 1979, 236:F494-F500.
118. Pedersen HD, Koch J, Poulsen K, et al. Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med 1995, 9:328-331.
119. Pedersen HD, Schutt T, Sondergaard R, et al. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation. J Vet Intern Med 2003, 17:178-184.
120. Pedersen HD Effects of mild mitral-valve insufficiency, sodium-intake, and place of blood-sampling on the renin-angiotensin system in dogs. Acta Vet Scand 1996, 37:109-118.
121. Pitt B, Zannad F, Remme WJ, et al. The Randomized Aldactone Evaluation Study Investigators: the effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
122. Pouchelon JL The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of the multicenter, prospective, randomized, double-blind, placebo-controlled, long term clinical trial. J Vet Cardiol 1999, 1:7-18. for the Benazepril in Canine Heart Disease Study Group (BENCH).
123. Priebe H, Heimann JC, Hedley-Whyte J Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac output in dogs. Circ Res 1980, 47:883-890.
124. Prosek R, Sisson DD, Oyama MA, et al. Plasma endothelin-1 immunoreactivity in normal dogs and dogs with acquired heart disease. J Vet Intern Med 2004, 18:840-844.
125. Reinhardt HW, Kaczmarczy KG, Eisele R, et al. Left atrial pressure and sodium balance in conscious dogs on a low sodium intake. Pflugers Arch 1977, 370:59-66.
126. Riegger GA, Elsner D, Kroner EP, et al. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanidine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 1988, 77:398-406.
127. Riegger GA, Liebau G, Kochsiek K Antidiuretic hormone in congestive heart failure. Am J Med 1982, 72:49-52.
128. Riegger GA, Liebau G, Holzschuh M, et al. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol 1984, 53:614-618.
129. Ritz E, Nowack R Detrimental and beneficial effects of converting enzyme inhibitors on the kidney. J Cardiol Pharmacol 1990, 16(suppl 4):570-575.
130. Roche BM, Schwartz D, Lehnhard RA, et al. Changes in concentrations of neuroendocrine hormones and catecholamines in dogs with myocardial failure induced by rapid ventricular pacing. Am J Vet Res 2003, 63:1413-1417.
131. Rose BD, Post TW Clinical physiology of acid base and electrolyte disorders 2001, 702. McGraw Hill, New York. ed 5.
132. Rose BD, Post TW Clinical physiology of acid base and electrolyte disorders 2001, 677. McGraw Hill, New York. ed 5.
133. Rose BD Diuretics. Kidney Int 1991, 39:336-352.
134. Roudebush P, Allen TA, Kuehn NF, et al. The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure. J Vet Intern Med 1994, 8:337-342.
135. Rush JE, Freeman LM, Brown DJ, et al. Clinical, echocardiographic, and neurohormonal effects of a sodium-restricted diet in dogs with heart failure. J Vet Intern Med 2000, 14:513-520.
136. Rush JE, Freeman LM, Brown DJ, et al. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy. J Am Anim Hosp Assoc 1998, 34:38-41.
137. Ryan MP Diuretics and potassium/magnesium depletion: directions for treatment. Am J Med 1987, 82(suppl 3A):38-47.
138. Sabbah HN, Sharov VG, Gupta RC, et al. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J Am Coll Cardiol 2000, 36:1698-1705.
139. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994, 89:2852-2859.
140. Schrier RW, Abraham WT Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577-585.
141. Schrier RW, Humphreys MH, Ufferman RC Role of cardiac output and the autonomic nervous system in the antinatriuretic response to acute constriction of the thoracic superior vena cava. Circ Res 1971, 29:490-498.
142. Schrier RW Pathogenesis of sodium and water retention in high output and low output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy. N Engl J Med 1988, 319:1065-1072. 1127-1134.
143. Seely JF, Dirks JH Site of action of diuretic drugs. Kidney Int 1977, 11:1-8.
144. Shimoyama H, Sabbah HN, Rosman H, et al. Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. J Am Coll Cardiol 1995, 25:768-772.
145. Sisson DD Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract 2004, 34:1105-1126.
146. Starling EH The influence of mechanized factors on lymph production. J Physiol (Lond) 1894, 10:14-155.
147. Staub NC Pathophysiology of pulmonary edema. Edema 1984, 719-746. Raven Press, New York. N.C. Staub, A.E. Taylor (Eds.).
148. Suki WN, Rector FC, Seldin DW The site of action of furosemide and other sulfonamide diuretics in the dog. J Clin Invest 1965, 44:1458-1469.
149. Suki WN Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure. Arch Intern Med 1989, 149:669-673.
150. Sun Y, Weber KT Cardiac remodelling by fibrous tissue-Role of local factors and circulating hormones. Ann Med 1998, 30(suppl 1):S3-S8.
151. Suzuki G, Morita H, Mishima T, et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 2002, 106:2967-2972.
152. Swales JD Magnesium deficiency and diuretics. BMJ 1982, 285:1377-1378.
153. Swan HJC, Ganz W, Forrester J, et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970, 283:447-451.
154. Tachibana H, Cheng HJ, Ukai T, et al. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure. Am J Physiol (Heart Circ Physiol) 2005, 288:H914-H922.
155. Taylor AE Capillary fluid filtration: Starling forces and lymph flow. Circ Res 1982, 49:557-575.
156. Thames MD Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents. Circ Res 1979, 44:8-15.
157. Thomas CJ, Woods RL Haemodynamic action of B-type natriuretic peptide substantially outlasts its plasma half-life in conscious dogs. Clin Exp Pharmacol Physiol 2003, 30:369-375.
158. Thomas JA, Marks BH Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978, 41:233-243.
159. Thrall DE, Calvert CA Radiographic evaluation of canine heartworm disease coexisting with right heart failure. Vet Radiol 1983, 24:124-126.
160. Uechi M, Matsuoka M, Kuwajima E, et al. The effects of the loop diuretics furosemide and torsemide on diuresis in dogs and cats. J Vet Med Sci 2003, 65:1057-1061.
161. van der Zander K, Houben AJ, Kroon AA, et al. Does brain natriuretic peptide have a direct renal effect in human hypertensives?. Hypertension 2003, 41:119-123.
162. Van Veldhuisen DJ, Genth-Zoth S, Brouwer J, et al. High-versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril. J Am Coll Cardiol 1998, 32:1811-1818.
163. Vasko MR, Brown-Cartwright D, Knochel JP, et al. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985, 102:314-318.
164. Vollmar AM, Montag C, Preusser U, et al. Atrial natriuretic peptide and plasma volume of dogs suffering from heart failure or dehydration. Zentralbl Veterinarmed A 1994, 41:548-557.
165. Vollmar AM, Preusser U, Gerbes AL, et al. Endothelin concentration in plasma of healthy dogs and dogs with congestive heart failure, renal failure, diabetes mellitus, and hyperadrenocorticism. J Vet Intern Med 1995, 9:105-111.
166. Wang W Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 1994, 24:571-575.
167. Ware WA, Lund DD, Subieta AR, et al. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. J Am Vet Med Assoc 1990, 197:1475-1481.
168. Watkins L, Burton JA, Haber E, et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 1976, 57:1606-1617.
169. Weaver LJ, Carrico CJ Congestive heart failure and edema. Edema 1984, 543-562. Raven Press, New York. N.C. Staub, A.E. Taylor (Eds.).
170. Weber KT Aldosterone and spironolactone in heart failure [editorial]. N Engl J Med 1999, 341:709-717.
171. Weber KT Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 2004, 44:1308-1310.
172. Wiener-Kronish JP, Goldstein R, Matthay RA, et al. Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension. Chest 1987, 92:967-970.
173. Yatsu T, Tomura Y, Tahara A, et al. Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs. Eur J Pharmacol 1997, 321:225-230.
174. Zucker IH, Share L, Gilmore JP Renal effects of left atrial distension in dogs with chronic congestive heart failure. Am J Physiol 1979, 236:H554-H560.
175. Pion PD, Kittleson MD Therapy for feline aortic thromboembolism. Current veterinary therapy X 1989, 295-301. WB Saunders, Philadelphia. R.W. Kirk (Ed.).
176. Uechi M, Sasaki T, Ueno K, et al. Cardiovascular and renal effects of carvedilol in dogs with heart failure. J Vet Med Sci 2002, 64:469-475.